Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data

home / publications / supplement / effectiveness-and-safety-of-arimoclomol-for-the-treatment-of-neurological-manifestations-of-niemann-pick-disease-type-c-a-review-of-clinical-trial-data

Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data

September 18th 2025

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences
AJMC®
All rights reserved.